Noahpharm Relocated,New Start
In golden autumn, Beijing Noahpharm Co. Ltd moved to a new address on October 11, 2021.
The new office is situated in 3rd Floor, Building 11, Zone 4, Hanwei International Plaza, Fengtai Science and Technology Park, Beijing. The superior geological location and convenient transportation shorten our communication distance with customers, helping us meet customers’ demand in a better and faster way. The new location also facilitates employee mobility.
The speech delivered by madam Shao Yan, the General Manager of Noahpharm unveiled the relocation ceremony. She first showed sincere gratitude for people caring for and supporting Noahpharm development. With five-year development, and powerful technical support from the publicly traded company Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (stock code: 688621), Noahpharm follows the tenet of customer centric and market led, enhances protocol innovation, integrates industry resources and forcefully implements the sustainable development strategy. With its leading technology and superior service, Noahpharm provides one-stop clinical solution, and has emerged as a long-term partner for many noted pharmaceutical manufacturers.
New address, new starting point. Noahpharm carries a pretty expectation for a bright future, which is exhibited by its superior geological location, broad and bright office, reasonable overall layout, comprehensive hardware, and well-established software and amenities and omnipresent corporate cultural elements. Standing beside the window, you will be embraced by flowers, cozy office, tea room, and lounge area and other amenities. Our employees can have a warmer and more beautiful office experience. In the brand-new office environment, Noahpharm will further expand the workforce, and further lift corporate service quality and operation efficiency. With the clear-cut mission, vision and development blueprint, Noahpharm is bound to have brighter development prospect.
This relocation not only reflects strength and confidence of Noahpharm, but also serves as an important symbol of its all-round development. In such a transition period, Noahpharm is ready to work harder along the journey ahead. Noahpharm staff will sail forward in the new path. Create brilliance by unity and co-write new chapter of excellence. Promote high-speed development of clinical research industry, and secure human health and welfare!
Previous Page
Next Page
Previous Page
Next Page
In order to speed up the establishment of an evidence system for the registration and evaluation of Chinese medicine which combines the traditional Chinese medicine (TCM) theory, human experience and clinical trial, standardize the writing of application documents for TCM theory and package inserts for TCM compound preparations of classic famous formula, under NMPA deployment, the Center for Drug Evaluation has coordinated formulation of the Guideline for Writing of Application Documents for Traditional Chinese Medicine (TCM) Theory of New TCM Compound Preparations (Trial) (Attachment 1), and the Guideline for Writing of Package Inserts for TCM Compound Preparations of Classic Famous Formula (Trial) (Attachment 2). In accordance with the Notice of Comprehensive Division, NMPA on Releasing the Technical Guideline for Pharmaceutical Products (YJZYG [2020] 9), after NMPA review and approval, it's hereby released and implemented since the date of release.
Noahpharm Presence in SAPA2021 China
Noahpharm Presence in SAPA2021 China
On October 14-15, 2021, hosted by Sino-American Pharmaceutical Professionals Association – China (SAPA-China), and guided and organized by the Management Committee of Suzhou High-tech Zone and the Management Committee of Suzhou Hushuguan Economy and Technology Development Zone, the Opportunity and Challenge for Chinese Biological Medicine Development and SAPA2021 China kicked off in Shishan International Convention Center in Suzhou High-tech Zone.
In golden autumn, Beijing Noahpharm Co. Ltd moved to a new address on October 11, 2021.The new office is situated in 3rd Floor, Building 11, Zone 4, Hanwei International Plaza, Fengtai Science and Technology Park, Beijing. The superior geological location and convenient transportation shorten our communication distance with customers, helping us meet customers’ demand in a better and faster way. The new location also facilitates employee mobility.
Provisions for the Supervision and Administration of Drug Production (No. 28 Order of the State Administration of Market Regulation, January 22, 2020)